Effect of drugs interacting with the dopaminergic receptors on glucose levels and insulin release in healthy and type 2 diabetic subjects

American Journal of Therapeutics

Volumn 15, Issue 4, 2008, Pages 397-402

  Contreras, Freddy ^a   Foullioux, Christian ^a   Pacheco, Betsy ^a   Maroun, Charbel ^a   Bolívar, Hector ^a   Lares, Mary ^a   Leal, Elliuz ^b   Cano, Raquel ^b   Bermúdez, Valmore ^b   Velasco, Manuel ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

^b UNIVERSIDAD DEL ZULIA   (Venezuela)

Author keywords

Dopamine; Dopaminergic agonists; Dopaminergic receptors; Hypertension; Insulin; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; DOPAMINE; DOPAMINE RECEPTOR; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METOCLOPRAMIDE; TRIACYLGLYCEROL; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT;

ADULT; ARTICLE; CARDIOVASCULAR RESPONSE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; NEUROENDOCRINE SYSTEM; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD PRESSURE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; ELECTROCARDIOGRAPHY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; TIME; VASCULAR ENDOTHELIUM;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; DOPAMINE; DOPAMINE AGENTS; DOPAMINE ANTAGONISTS; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FEMALE; HEART RATE; HUMANS; INSULIN; MALE; METOCLOPRAMIDE; MIDDLE AGED; RECEPTORS, DOPAMINE; TIME FACTORS;

EID: 51649106894     PISSN: 10752765     EISSN: None     Source Type: Journal    
DOI: 10.1097/MJT.0b013e318160c353     Document Type: Article

References (25)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
2. Velasco M, Gilbert CA, Rutledge CO, et al. Antihypertensive effect of a dopamine beta hydroxylase inhibitor, bupicomide: a comparison with hydralazine. Clin Pharmacol Ther. 1975;18:145-153.
3. Luchsinger A, Velasco M, Urbina A, et al. Comparative effects of dopaminergic agonists on cardiovascular, renal, and rennin-angiotensin systems in hypertensive patients. J Clin Pharmacol. 1992;32:55-60.
4. Murphy MB. Dopamine: a role in the pathogenesis and treatment of hypertension. J Hum Hypertens. 2000; 14(Suppl 1):S47-S50.
5. Zhu XZ, Luo LG. Effect of nitroprusside (nitric oxide) on endogenous dopamine release from rat striatal slices. J Neurochem. 1992;59:932-935.
6. van den Buuse M, Webber KM. Endothelin and dopamine release. Progr Neurobiol 2000;60:385-405.
7. Buikema H, van Gust WH, van Veldhuisen DJ, et al. Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine. Cardiovasc Res. 1993;27:2118-2124.
8. Yuasa S, Li X, Hitomi H, et al. Sodium sensitivity and sympathetic nervous system in hypertension induced by long-term nitric oxide blockade in rats. Clin Exp Pharmacol Physiol. 2000;27:18-24.
9. Davies MG, Huynh TT, Hagen PO. Characterization of dopamine-mediated relaxation in experimental vein bypass grafts. J Surg Res. 2000;92:103-107.
10. Januszewicz A, Lapiski M, Symonides B, et al. Elevated endothelin-1 plasma concentration in patients with essential hypertension. J Cardiovasc Risk. 1994;1:81-85.
11. Liang Y, Jetton TL, Lubkin M, et al. Bromocriptine/SKF38393 ameliorates islet dysfunction in the diabetic (db/db) mouse. Cell Mol Life Sci. 1998;54:703-711.
12. Martin G, Forte P, Luchsinger A, et al. Effect of intravenous dopamine on blood pressure and plasma insulin in hypertensive patients. Eur J Clin Pharmacol. 1993;45:503-505.
13. Scislowski PW, Tozzo E, Zhang Y, et al. Biochemical mechanisms responsible for the attenuation of diabetic and obese conditions in ob /ob mice treated with dopaminergic agonists. Int J Obes Relat Metab Disord. 1999;23:425-431.
14. Velasco M, Urbina-Quintana A, Andrews-Figueroa P, et al. Effect of indoramin and propranolol on cardiovascular response to cold in hypertensive patients. Clin Pharmacol Ther. 1982;32:7-11.
15. Blanco M, Jelambi I, Perez G, et al. The effect of intravenous metoclopramide on blood pressure in normotensive and hypertensive subjects. Int J Clin Pharmacol Ther. 1996;34:390-392.
16. Martin G, Forte P, Luchsinger A, et al. Dopamine-induced antihypertensive effects and plasma insulin rise are blocked by metoclopramide in labetalol-treated patients. J Clin Pharmacol 1994;34:91-94.
17. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(Suppl 1): 5S-S10.
18. Friedewald WI, Levy RI, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without the use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
19. Owen WE, Roberts WL. Cross-reactivity of three recombinant insulin analogs with five commercial insulin immunoassays. Clin Chem. 2004;50:257-259.
20. Bergmeyer HU. Standardization of enzyme assays. Clin Chem. 1972;18:1305-1311.
21. Trivelli LA, Ranney HM, Lai HT. Hemoglobin components in patients with diabetes mellitus. N Engl J Med. 1971;284:353-357.
22. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412-419.
23. Contreras F, Rivera M, Vásquez J, et al. Endothelial dysfunction in arterial hypertension. J Hum Hypertens. 2000;14(Suppl 1):S20-S25.
24. Contreras F, Gonzalez M, Clemente IC y Velasco M. Efectos de las Drogas dopaminèrgicas sobre el sistema cardiovascular y liberaciòn de insulina en sujetos sanos y diabèticos tipo 2. Arch Venezolanes Farm Ter. 2005;24: 42-49.
25. Velasco M, Arreaza R, Luchsinger A, et al. Cardiovascular and hormonal effects of domperidone, a peripheral dopaminergic blocker, in bromocriptine-treated hypertensive patients. Am J Ther. 1995;2:451-454.